CYTOGARD OD CAP

AboutTrimetazidine is a unique metabolic agent primarily utilized in cardiology for its anti-ischemic and cardioprotective properties, particularly in the management of angina pectoris. Its mechanism of action differs from traditional anti-anginal drugs as it does not directly affect hemodynamic parameters such as heart rate or blood pressure. Instead, trimetazidine acts by inhibiting the beta-oxidation of long-chain fatty acids, which in turn shifts myocardial energy metabolism towards glucose oxidation. Glucose oxidation is a more efficient process, requiring less oxygen to produce the same amount of adenosine triphosphate (ATP), the primary energy currency of cells. This metabolic reorientation helps to preserve cellular energy levels and maintain myocardial function under ischemic conditions, thereby protecting myocardial cells from the detrimental effects of oxygen deprivation. By optimizing energy utilization, trimetazidine effectively reduces the frequency and severity of angina attacks and improves exercise capacity in patients with stable angina, offering a valuable therapeutic option.UsesProphylactic treatment of angina pectorisAdjunctive therapy for vertigo of vascular originAdjunctive therapy for tinnitus of vascular originImprovement of visual field disturbances of vascular originDirections For UseTake orally, usually once daily with a meal. Swallow the tablet whole; do not chew or crush to ensure controlled release.BenefitsReduces the frequency of angina attacksImproves exercise capacity in angina patientsEnhances myocardial energy metabolismDoes not significantly affect heart rate or blood pressureMay improve symptoms of vertigo and tinnitusOffers cardioprotective effects during ischemiaSide EffectsDizzinessHeadacheNausea or vomitingAbdominal painDiarrheaRash or itchingAsthenia (weakness)PalpitationsExtrapyramidal symptoms (e.g., tremor, rigidity, gait instability)Sleep disturbancesOrthostatic hypotensionMalaiseSafety MeasuresAlcohol - No specific contraindication, but excessive alcohol intake can exacerbate dizziness or lightheadedness.Pregnancy - Not recommended during pregnancy due to insufficient data. Consult a doctor.Breastfeeding - Not recommended during breastfeeding as it is unknown if it is excreted in human milk. Consult a healthcare professional.Liver - Use with caution in patients with moderate liver impairment. Dose adjustment may be considered.Kidney - Contraindicated in patients with severe renal impairment (creatinine clearance < 30 mL/min). Dose adjustment is required for moderate impairment.Lung - Generally considered safe for patients with lung conditions as it does not directly affect respiratory function.DisclaimerMedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.Our goal is to complement, not replace, the essential doctor-patient relationship.